Darius Kharabi is COO of Lagunita Biosciences. Prior to Lagunita, Mr. Kharabi was the General Manager of EMBA Medical Ltd, an early stage endovascular device company, and an entrepreneur-in-residence with Intersect Partners, a medical device incubator. Earlier, he served as Vice President, Corporate Development and International Sales at OrthAlign Inc., a commercial-stage orthopedic surgery navigation company, where his responsibilities included the launch of the KneeAlign® total knee arthroplasty navigation product line in North America, Europe, Asia, and Australia. Prior to that, Darius was a Partner at VLP Law Group LLP and a biotechnology licensing attorney at Wilson, Sonsini Goodrich & Rosati PC. Mr. Kharabi received his B.S. in Biochemistry from Georgetown University and his J.D. and M.B.A. degrees from Stanford University.
Current role